» Articles » PMID: 31612867

β-arrestin-2 Enhances Intestinal Epithelial Apoptosis in Necrotizing Enterocolitis

Overview
Specialty Geriatrics
Date 2019 Oct 16
PMID 31612867
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Apoptosis among intestinal epithelial cells contributes to necrotizing enterocolitis (NEC), a severe intestinal disease that particularly affects premature infants. β-arrestin-2, an important regulator of G-protein-coupled receptors, is expressed in intestinal epithelial cells, where its activation promotes apoptosis. We found that β-arrestin-2 was overexpressed in both human and murine NEC samples. β-arrestin-2-deficient mice were protected from endoplasmic reticulum stress and NEC development. The endoplasmic reticulum-resident chaperone BiP was found to promote intestinal epithelial cell survival. Pretreatment of intestinal epithelial cells or mice with the BiP inhibitor HA15 increased cell apoptosis and promoted NEC development. β-arrestin-2 bound to BiP and promoted its polyubiquitination and degradation, thereby facilitating the release of the pro-apoptotic molecule BIK from BiP. Silencing β-arrestin-2 downregulated apoptosis by increasing BiP levels, which suppressed endoplasmic reticulum stress. This study suggests that β-arrestin-2 induces NEC development by inhibiting BiP, thereby triggering apoptosis in response to endoplasmic reticulum stress. Thus, novel therapeutic strategies to inhibit β-arrestin-2 may enhance the treatment of NEC.

Citing Articles

β-arrestin2: an emerging player and potential therapeutic target in inflammatory immune diseases.

Gao P, Li L, Chen T, Li N, Li M, Zhang H Acta Pharmacol Sin. 2024; .

PMID: 39349766 DOI: 10.1038/s41401-024-01390-w.


Antenatal Infection Causes Colonic Mucus Barrier Defects: Implications for Intestinal Pathologies.

van Gorp C, de Lange I, Hutten M, Lopez-Iglesias C, Massy K, Kessels L Int J Mol Sci. 2024; 25(7).

PMID: 38612809 PMC: 11011967. DOI: 10.3390/ijms25074000.


Active polypeptide MDANP protect against necrotizing enterocolitis (NEC) by regulating the PERK-eIF2ɑ-QRICH1 axis.

Huo J, Zhang R, Wu X, Fu C, Hu J, Hu X Sci Rep. 2023; 13(1):22912.

PMID: 38129421 PMC: 10739873. DOI: 10.1038/s41598-023-44194-4.


HSPA5 Inhibitor Meliorate DSS-Induced Colitis through HSPA1A/CHIP.

Gao F, Fan H, Xue L, Shou Z, Zhu F, Yu T Dis Markers. 2022; 2022:7115181.

PMID: 35872700 PMC: 9300310. DOI: 10.1155/2022/7115181.


Sulforaphane Ameliorates the Intestinal Injury in Necrotizing Enterocolitis by Regulating the PI3K/Akt/GSK-3 Signaling Pathway.

Bao Z, Mi Y, Xiong X, Wang X Can J Gastroenterol Hepatol. 2022; 2022:6529842.

PMID: 35600210 PMC: 9117068. DOI: 10.1155/2022/6529842.


References
1.
Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

2.
Luttrell L, Ferguson S, Daaka Y, Miller W, Maudsley S, Della Rocca G . Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999; 283(5402):655-61. DOI: 10.1126/science.283.5402.655. View

3.
Caplan M, Hedlund E, Adler L, Hsueh W . Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol. 1994; 14(6):1017-28. DOI: 10.3109/15513819409037698. View

4.
Lin P, Stoll B . Necrotising enterocolitis. Lancet. 2006; 368(9543):1271-83. DOI: 10.1016/S0140-6736(06)69525-1. View

5.
Kaser A, Adolph T, Blumberg R . The unfolded protein response and gastrointestinal disease. Semin Immunopathol. 2013; 35(3):307-19. PMC: 3661271. DOI: 10.1007/s00281-013-0377-5. View